By
Trending Posts
Odyssey and Terray Forge AI-Powered Partnership to Advance…
Boston and Los Angeles – Oct 28, 2024 With Odyssey’s established track record in immunology and Terray’s cutting-edge…
Dyno Therapeutics and Roche Expand Strategic Partnership for…
October 24, 2024 Dyno Therapeutics has expanded its collaboration with Roche to advance next-generation adeno-associated virus (AAV) vectors…
Six Ways Johnson & Johnson is Leveraging AI…
October 10, 2024 Johnson & Johnson is at the forefront of integrating Artificial Intelligence (AI) to drive healthcare…
BullFrog AI Publishes Data Highlighting Potential of BF-114…
Gaithersburg, Md – Oct 9 2024 BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW), a technology-enabled drug development company…
ProJenX and Unlearn AI Collaborate to Advance AI-Powered…
San Francisco – September 27, 2024 ProJenX, a clinical-stage biotech company, has partnered with Unlearn AI to enhance…
Novartis and Generate:Biomedicines Announce Strategic AI-Driven Protein Therapeutics…
Somerville, MA — Sept 24, 2024 Combining AI innovation with pharma expertise to accelerate drug development and tackle…
Eli Lilly and Genetic Leap Forge $409M Strategic…
New York – Sept 24 2024 Eli Lilly and Company (NYSE: LLY) has entered into a landmark $409…
Rakovina Therapeutics and Variational AI Partner to Advance…
Vancouver, BC – September 17, 2024 Rakovina Therapeutics Inc. (TSX-V: RKV), a Canadian biopharmaceutical company focused on developing…
Gilead Expands AI-Driven Drug Discovery Capabilities Through Strategic…
BURLINGAME, California – Sept 10, 2024 Gilead Sciences, Inc. (Nasdaq: GILD) and Genesis Therapeutics have entered into a…
Trending Posts
Latest Stories
Will XtalPi’s AI-Driven Acquisition of LCC Redraw the Map of Chiral Drug Discovery?
Key Highlights: AI Meets Chiral Chemistry in Strategic UK AcquisitionXtalPi Holdings Ltd. (HKEX: 2228), the…
Is DeepCure’s AI-Designed Oral STAT6 Inhibitor the Next Breakthrough in Atopic Dermatitis Treatment?
Key Highlights: Oral Option for Dupilumab-Class PatientsDeepCure’s newly nominated candidate DC-15442 offers a breakthrough alternative…
How Novo Nordisk and Deep Apple’s $812M AI-Powered Alliance Redefine the Future of Oral Obesity Drugs?
Key Highlights: A Bold Break from Incretin DependencyNovo Nordisk’s new alliance with Deep Apple Therapeutics…
How Will HEALWELL AI and Orion Health Transform the $160B US Digital Health Market with AI-Driven Preventative Care?
Key Highlights: Strategic Expansion into US Healthcare MarketHEALWELL AI Inc., following its acquisition of Orion…
Gallery
